Skip to main content
Clinical Trials/JPRN-UMIN000049004
JPRN-UMIN000049004
Completed
N/A

A verification study of the prevention of frailty: a randomized, placebo-controlled, double-blind, parallel-group comparison study - A verification study of the prevention of frailty

ORTHOMEDICO Inc.0 sites66 target enrollmentSeptember 22, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Healthy Japanese subjects
Sponsor
ORTHOMEDICO Inc.
Enrollment
66
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 22, 2022
End Date
March 25, 2023
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2\. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3\. Subjects currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4\. Subjects who use or take "Foods for Specified Health Uses," or "Foods with Functional Claims" in daily 5\. Subjects who are currently taking medications (including herbal medicines) and supplements 6\. Subjects who consciously take dietary fiber and oligosaccharides 7\. Subjects who are allergic to medicines and/or the test food related products 8\. Subjects who have an exercise habit of two times or more per week and 30 minutes or more each time, and been doing it for one year or more 9\. Subjects who suffer from COVID\-19 10\. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 11\. Subjects who are judged as ineligible to participate in this study by the physician

Outcomes

Primary Outcomes

Not specified

Similar Trials